Previous Nav
Net Change on 08-08-2025
PersonalFN Rating
Category
Assets (Cr.)
Expense Ratio
Fund House
Launch Date
Benchmark
Minimum Investment (₹)
Minimum Addl Investment (₹)
Exit Load (%)
Minimum SIP Investment (₹)
Minimum STP Investment (₹)
Minimum SWP Investment (₹)
52 Week Low Nav (₹)
52 Week Low Nav Date
52 Week High Nav (₹)
52 Week High Nav Date
Returns upto 1 year is Absolute, and above 1 year are Compounded Annualised
Sun Pharmaceutical Industries Ltd.
Divi's Laboratories Ltd.
Max Healthcare Institute Ltd.
Cipla Ltd.
Lonza Group
Lupin Ltd.
Gland Pharma Ltd.
Mankind Pharma Ltd.
Acutaas Chemicals Ltd.
Krishna Institute of Medical Sciences Ltd.
Fortis Healthcare Ltd.
Biocon Ltd.
Abbott India Ltd.
Laurus Labs Ltd.
Aster DM Healthcare Ltd.
Torrent Pharmaceuticals Ltd.
Concord Biotech Ltd.
Jupiter Life Line Hospitals Ltd.
TREPS
Polymedicure Ltd.
Aether Industries Ltd.
Alkem Laboratories Ltd.
Anthem Biosciences Ltd.
Rainbow Children's Medicare Ltd.
Aurobindo Pharma Ltd.
Cohance Lifesciences Ltd.
Vijaya Diagnostic Centre Ltd.
Pfizer Ltd.
Akums Drugs & Pharmaceuticals Ltd.
Gufic Biosciences Ltd.
Sanofi Consumer Healthcare India Ltd.
182 DAY T-BILL 20.11.25
Net Receivable / Payable
Pharmaceuticals & Drugs
Hospital & Healthcare Services
Miscellaneous
Medical Equipment/Supplies/Accessories
Chemicals
16/03/2018
30/01/2015
04/01/2005
06/09/2004
22/09/2003
Cash
Equity
Sovereign
SBI Healthcare Opportunities Fund is a Equity - Sectoral Fund - Pharma & Health Care fund and belongs to SBI Mutual Fund. It was launched on 03-Jul-1999 and currently has an AUM of ₹4,026.55 crore. SBI Healthcare Opportunities Fund is benchmarked against BSE Health Care - TRI as primary index and BSE SENSEX - TRI as secondary index.
The NAV of SBI Healthcare Opportunities Fund ended down ₹-3.95(-1.47%)yesterday to ₹265.1543.
Among its top 3 holdings the fund has exposure to Sun Pharmaceutical Industries Ltd., and
The SBI Healthcare Opportunities Fund is managed by Tanmaya Desai .
9th Floor, Crescenzo, C - 38 & 39 G Block, BKC, Bandra (East) Mumbai - 400 051